South Street Advisors »

Halozyme Therapeutics shares owned by South Street Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by South Street Advisors from 13F filings

Historical chart of South Street Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by South Street Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by South Street Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $11M 230k 47.81
2024-09-30 $9.8M 171k 57.24